Cargando…
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Transforming growth factor-β (TGF-β) signaling has a paradoxical role in cancer progression, and it acts as a tumor suppressor in the early stages but a tumor promoter in the late stages of cancer. Once cancer cells are generated, TGF-β signaling is responsible for the orchestration of the immunosup...
Autores principales: | Shi, Xueke, Yang, Jin, Deng, Shuzhi, Xu, Hongdan, Wu, Deyang, Zeng, Qingxiang, Wang, Shimeng, Hu, Tao, Wu, Fanglong, Zhou, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482317/ https://www.ncbi.nlm.nih.gov/pubmed/36115986 http://dx.doi.org/10.1186/s13045-022-01349-6 |
Ejemplares similares
-
Microenvironment in Oral Potentially Malignant Disorders: Multi-Dimensional Characteristics and Mechanisms of Carcinogenesis
por: Deng, Shuzhi, et al.
Publicado: (2022) -
TGF-βRII regulates glucose metabolism in oral cancer-associated fibroblasts via promoting PKM2 nuclear translocation
por: Wu, Fanglong, et al.
Publicado: (2022) -
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
por: Wu, Fanglong, et al.
Publicado: (2021) -
Down-regulation of DNA key protein-FEN1 inhibits OSCC growth by affecting immunosuppressive phenotypes via IFN-γ/JAK/STAT-1
por: Wang, Shimeng, et al.
Publicado: (2023) -
TGFβ Signaling in the Pancreatic Tumor Microenvironment
por: Principe, Daniel R., et al.
Publicado: (2021)